Compositions and methods employing nmda antagonists for...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 45/06 (2006.01) A61K 31/08 (2006.01) A61K 31/675 (2006.01) A61P 23/00 (2006.01)

Patent

CA 2697739

Provided herein are compositions, combinations, and methods comprising NMDA antagonists including, but not limited to, NMDA glutamate receptor antagonists such as [2-(8,9-dioxo-2,6- diazabicyclo[5.2.0]non-1-(7)-en-2-yl)alkyl]phosphonic acid and derivatives thereof, which are effective in reducing the amount of anesthetic required to maintain anesthesia (i.e. to achieve an anesthetic-sparing effect).

L'invention propose des compositions, des combinaisons et des procédés comportant des antagonistes de NMDA comprenant, mais sans s'y limiter, des antagonistes des récepteurs du glutamate NMDA tels que l'acide [2-(8,9-dioxo-2,6-diazabicyclo[5.2.0]non-1-(7)-en-2-yl)alkyl]phosphonique et des dérivés de celui-ci, qui sont efficaces dans la réduction de la quantité d'anesthésique nécessaire pour maintenir l'anesthésie (à savoir, pour obtenir un effet d'épargne de l'anesthésique).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Compositions and methods employing nmda antagonists for... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Compositions and methods employing nmda antagonists for..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods employing nmda antagonists for... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1870492

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.